Functional significance of globotriaosyl ceramide in interferon-α2/type 1 interferon receptor-mediated antiviral activity

被引:0
|
作者
Khine, AA
Lingwood, CA
机构
[1] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Lab Med, Toronto, ON, Canada
[3] Univ Toronto, Dept Pathobiol, Toronto, ON, Canada
[4] Univ Toronto, Dept Biochem, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The N-terminus of the type 1 interferon receptor subunit IFNAR1, has high amino acid sequence similarity to the receptor binding B subunit of the Escherichia coli-derived verotoxin 1, VT1. The glycolipid, globotriaosyl ceramide (Cb,: Gal alpha(1) --> 4 Gal beta 1 --> 4 Glu beta 1 --> 1 Cer) is the specific cell receptor for VT1. Gb(3)-deficient variant cells selected for VT resistance are cross-resistant to interferon-alpha (IFN-alpha)-mediated antiproliferative activity. The association of eIFNAR1 with Gal alpha 1 --> 4 Gal containing glycolipids has been previously shown to be important for the receptor-mediated IFN-alpha signal transduction for growth inhibition. The crucial role of Gb(3) for the signal transduction of IFN-alpha-mediated antiviral activity is now reported. IFN-alpha-mediated antiviral activity, nuclear translocation of activated Stat1, and increased expression of PKR were defective in Gb(3)-deficient vero mutant cells, although the surface expression of IFNAR1 was unaltered. The VT1B subunit was found to inhibit IFN-alpha-mediated antiviral activity, Stat1 nuclear translocation and PKR upregulation. Unlike VT1 cytotoxicity, IFN-alpha-induced Stat1 nuclear translocation was not inhibited when RME was prevented, suggesting that the accessory function of Gb(3) occurs at the plasma membrane. IFN-alpha antiviral activity was also studied in Gb(3)-positive MRC-5 cells, which are resistant to IFN-alpha growth inhibition, partially resistant to VT1 but still remain fully sensitive to IFN-alpha antiviral activity, and two astrocytoma cell lines expressing different Gb(3) fatty acid isoforms. In both systems, long chain fatty acid-containing Gb(3) isoforms, which are less effective to mediate VT1 cytotoxicity, were found to correlate with higher IFN-alpha-mediated antiviral activity. Inhibition of Gb(3) synthesis in tote prevented IFN-alpha antiviral activity in all cells. We propose that the long chain Gb(3) fatty isoforms preferentially remain in the plasma membrane, and by associating with IFNAR1, mediate IFN-alpha antiviral signaling, whereas short chain Gb(3) fatty acid isoforms are preferentially internalized to mediate VT1 cytotoxicity and IFNAR1-dependent IFN-alpha growth inhibition. J. Cell. Physiol. 182:97-108, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:97 / 108
页数:12
相关论文
共 50 条
  • [1] Functional significance of globotriaosylceramide in α2 interferon type I interferon receptor mediated anti viral activity.
    Khine, AA
    Lingwood, CA
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 119A - 119A
  • [2] CELL-SURFACE RECEPTOR-MEDIATED INTERNALIZATION OF INTERFERON - ITS RELATION TO THE ANTIVIRAL ACTIVITY OF INTERFERON
    YONEHARA, S
    ISHII, A
    YONEHARATAKAHASHI, M
    JOURNAL OF GENERAL VIROLOGY, 1983, 64 (NOV): : 2409 - 2418
  • [3] Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-β1a monkeys
    Mager, DE
    Neuteboom, B
    Efthymiopoulos, C
    Munafo, A
    Jusko, WJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (01): : 262 - 270
  • [4] Receptor-Mediated Pharmacokinetic/Pharmacodynamic Model of Interferon-β 1a in Humans
    Donald E. Mager
    William J. Jusko
    Pharmaceutical Research, 2002, 19 : 1537 - 1543
  • [5] Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-β 1a in humans
    Mager, DE
    Jusko, WJ
    PHARMACEUTICAL RESEARCH, 2002, 19 (10) : 1537 - 1543
  • [6] Deficient interferon-γ receptor-mediated signaling in neonatal macrophages
    Maródi, L
    ACTA PAEDIATRICA, 2002, 91 : 117 - 119
  • [7] TYPE III INTERFERON (IFN-λ) ANTAGONIZES THE ANTIVIRAL ACTIVITY OF INTERFERON-α IN VITRO
    Bordi, L.
    Lalle, E.
    Lapa, D.
    Caglioti, C.
    Quartu, S.
    Capobianchi, M. R.
    Castilletti, C.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2013, 27 (04): : 1001 - 1009
  • [8] ANTIVIRAL ACTIVITY OF AUTOCRINE INTERFERON-BETA REQUIRES THE PRESENCE OF A FUNCTIONAL INTERFERON TYPE-I RECEPTOR
    ROUSSEAU, V
    CREMER, I
    LAURET, E
    RIVIERE, I
    AGUET, M
    DEMAEYER, E
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (09): : 785 - 789
  • [9] Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-α-2b
    Koyama, AH
    Arakawa, T
    Adachi, A
    MICROBES AND INFECTION, 1999, 1 (13) : 1073 - 1077
  • [10] Interferon-γ and interferon-γ receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting
    Tiroch, K
    von Beckerath, N
    Koch, W
    Lengdobler, J
    Joost, A
    Schömig, A
    Kastrati, A
    ATHEROSCLEROSIS, 2005, 182 (01) : 145 - 151